| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |